We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

4063:TSEShin-Etsu Chemical Co Ltd Analysis

Data as of 2026-09-04 - not real-time

¥5,800.00

Latest Price

4/10Risk

Risk Level: Medium

Executive Summary

At ¥5,800.00, Shin-Etsu Chemical Co., Ltd. shows no decisive moving-average alignment, leaving the trend neutral. It has lost 16.8% over the past 30 days. With RSI at 32.7 the momentum picture is approaching oversold, alongside a bullish MACD signal. Price has been bracketed by support at ¥5,785.00 and resistance at ¥6,508.00.
On valuation the read is fair — an earnings multiple of 23.0, absent a reliable peer benchmark. Sell-side targets cluster 34.0% above the current quote. Revenue is growing at 5.4% on a 18.4% profit margin. The 1.98% dividend yield looks covered by current payout levels.
Risk scores 4 out of 10, which is moderate for this asset class. With 30-day volatility of 37.4%, a beta of 0.76 and a maximum drawdown of 27.1%, position sizing matters here. The wider market backdrop reads extreme greed at 96 on the fear-greed composite.
Near-term and long-term part ways here — hold short-term against buy longer out, with 5/10 conviction on the long call.

Top Market Events

Shin-Etsu Chemical TSE:4063 has launched a large self-tender share buyback, signaling a major capital allocation move...Exploring the Strategic Portfolio Adjustments in Q2 2026Barron's1monShin-Etsu Chemical Co. Ltd.About Shin-Etsu Chemical Co. Ltd. Shin-Etsu Chemical Co., Ltd. engages in the...

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 4/10

Key Factors

  • Trading below the 200-day average of 6133.98
  • MACD momentum is positive
  • 30-day price change of -16.8%

Medium Term

1–3 years
Positive
Model confidence: 4/10

Key Factors

  • Trading below the 200-day average of 6133.98
  • Analyst targets imply +34.0% versus the current price
  • MACD momentum is positive

Long Term

> 3 years
Positive
Model confidence: 5/10

Key Factors

  • Analyst targets imply +34.0% versus the current price
  • Profit margin of 18.4% is healthy
  • P/E ratio of 23.0

Key Metrics & Analysis

Financial Health

Revenue Growth5.40%
Profit Margin18.36%
P/E Ratio23.0
ROE11.23%
ROA7.29%
Debt/Equity5.49
P/B Ratio2.4
Op. Cash Flow¥746.0B
Free Cash Flow¥243.6B

Technical Analysis

TrendNeutral
RSI32.7
Support¥5,785.00
Resistance¥6,508.00
MA 20¥6,101.40
MA 50¥6,508.48
MA 200¥6,133.99
MACDBullish
VolumeStable
Fear & Greed Index95.86

Valuation

Fair Value¥2,848.27
Target Price¥7,774.71
Upside/Downside34.05%
GradeFair
TypeBlend
Dividend Yield1.98%

Risk Assessment

Beta0.76
Volatility37.36%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskMedium
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.